학술논문
Hydrogel formulation of phosphosulindac allows once-a-day ocular dosing and limits its biodistribution to the anterior chamber: Application to dry eye disease treatment
Document Type
Article
Author
Source
In: Journal of Drug Delivery Science and Technology . (Journal of Drug Delivery Science and Technology, January 2022, 67)
Subject
Language
English
ISSN
17732247